Advertisement
U.S. markets open in 8 hours 49 minutes
  • S&P Futures

    5,208.25
    -6.50 (-0.12%)
     
  • Dow Futures

    39,209.00
    -14.00 (-0.04%)
     
  • Nasdaq Futures

    18,179.00
    -52.50 (-0.29%)
     
  • Russell 2000 Futures

    2,048.40
    -1.40 (-0.07%)
     
  • Crude Oil

    82.58
    -0.14 (-0.17%)
     
  • Gold

    2,163.90
    -0.40 (-0.02%)
     
  • Silver

    25.30
    +0.03 (+0.12%)
     
  • EUR/USD

    1.0872
    -0.0005 (-0.04%)
     
  • 10-Yr Bond

    4.3400
    -4.3400 (-100.00%)
     
  • Vix

    14.33
    -0.08 (-0.56%)
     
  • GBP/USD

    1.2716
    -0.0013 (-0.10%)
     
  • USD/JPY

    149.9650
    +0.8670 (+0.58%)
     
  • Bitcoin USD

    65,393.07
    -2,881.56 (-4.22%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,722.55
    -4.87 (-0.06%)
     
  • Nikkei 225

    39,772.99
    +32.59 (+0.08%)
     

Iovance Biotherapeutics: 3Q Earnings Snapshot

Iovance Biotherapeutics: 3Q Earnings Snapshot

SAN CARLOS, Calif. (AP) _ Iovance Biotherapeutics Inc. (IOVA) on Tuesday reported a loss of $33.8 million in its third quarter.

On a per-share basis, the San Carlos, California-based company said it had a loss of 36 cents.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share.

Iovance Biotherapeutics shares have increased 10 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $8.80, a climb of 14 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA

Advertisement